NurExone Biologic Secures Funding and Expands Market Presence

EnerSpar Corp. (TSE:NRX) has released an update.

NurExone Biologic Inc. successfully closed its non-brokered private placement, raising over $1.7 million to boost its asset development and corporate functions. The company has also engaged Independent Trading Group and Oak Hill Financial Inc. for market-making and investor relations services, aiming to enhance liquidity and market presence.

For further insights into TSE:NRX stock, check out TipRanks’ Stock Analysis page.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.